Skip to main content
SpringerLink
Log in

Hospital statistics for antibiotics: defined versus prescribed daily dose

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Defined daily doses (DDD) are widely used as a unit to measure drug use in hospital and community settings. However, discrepancies exist between DDD and actual prescribed daily dose (PDD). The present study aims at estimating an alternative PDD (PDD-proxy) to calculate rates of systemic antibiotic consumption and to compare these results with those obtained using DDD.

Methods

The study considered a 9-year period (2004–2012) and included the 17 Health Trusts (HTs) in the Emilia-Romagna Region, Italy. Drugs under study were antibacterials for systemic use (group J01). Data were obtained from the database for hospital drug prescription of Emilia-Romagna Region. The PDD-proxy was estimated by averaging the doses of antibiotic prescriptions from a point prevalence survey for healthcare-associated infections and antimicrobial use, conducted in Emilia-Romagna hospitals in 2012.

Results

Significant discrepancies between DDD and PDD were observed, especially for some antibiotics, resulting in DDD rates that were systematically higher than PDD-proxy rates. In 2012, HT median rates of antibiotic consumption were 90 DDD/100 bed days and 70 PDD-proxy/100 bed-days. However, PDD-proxy and DDD rates showed comparable trends within HTs, although some HTs ranked differently when one or the other measure was used. Interquartile ranges of DDD rates were systematically wider than those of PDD-proxy rates in most years in the period of interest.

Conclusions

Comparison of HT antibiotic consumption using DDDs may artificially increase observed differences and affect the true HT ranking. Therefore, an additional unit of measurement is useful for in-depth analysis at the local level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, ECDC, 2012.

  2. Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013;303:388–95.

    Article  PubMed  Google Scholar 

  3. Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2013;41:137–42.

    Article  PubMed  CAS  Google Scholar 

  4. Fournier S, Brun-Buisson C, Jarlier V. Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE). Antimicrob Resist Infect Control. 2012;1:9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dumartin C, L’Heriteau F, Pefau M, Bertrand X, Jarno P, Boussat S, et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother. 2010;65:2028–36.

    Article  PubMed  CAS  Google Scholar 

  6. Filius PM, Liem TB, van der Linden PD, Janknegt R, Natsch S, Vulto AG, et al. HA. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother. 2005;55:805–8.

    Article  PubMed  CAS  Google Scholar 

  7. Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, Weber R. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection. 2008;36:549–59.

    Article  PubMed  CAS  Google Scholar 

  8. Muller-Pebody B, Muscat M, Pelle B, Klein BM, Brandt CT, Monnet DL. Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001. J Antimicrob Chemother. 2004;54:1122–6.

    Article  PubMed  Google Scholar 

  9. Ronning M, Blix HS, Strom H, Skovlund E, Andersen M, Stichele RV. Problems in collecting comparable national drug use data in Europe: the example of antibacterials. Eur J Clin Pharmacol. 2003;58:843–9.

    PubMed  Google Scholar 

  10. Zarb P, Ansari F, Muller A, Vankerckhoven V, Davey PG, Goossens H. Drug utilization 75% (DU75%) in 17 European hospitals (2000–2005): results from the ESAC-2 Hospital Care Sub Project. Curr Clin Pharmacol. 2011;6:62–70.

    Article  PubMed  Google Scholar 

  11. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2013. Oslo, WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway, 2012.

  12. de With K, Maier L, Steib-Bauert M, Kern P, Kern WV. Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator? Infection. 2006;34:91–4.

    Article  PubMed  Google Scholar 

  13. de With K, Bestehorn H, Steib-Bauert M, Kern WV. Comparison of defined versus recommended versus prescribed daily doses for measuring hospital antibiotic consumption. Infection. 2009;37:349–52.

    Article  PubMed  Google Scholar 

  14. Fitzpatrick RW, Edwards CM. Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom. Pharm World Sci. 2008;30:73–8.

    Article  PubMed  Google Scholar 

  15. Grimmsmann T, Himmel W. Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes? Eur J Clin Pharmacol. 2011;67:847–54.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Haug JB, Reikvam A. WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance. J Antimicrob Chemother. 2013;68:2940–7.

    Article  PubMed  CAS  Google Scholar 

  17. Muller A, Monnet DL, Talon D, Henon T, Bertrand X. Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol. 2006;61:585–91.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664–70.

    Article  PubMed  CAS  Google Scholar 

  19. Koristkova B, Grundmann M, Brozmanova H. Differences between prescribed daily doses and defined daily doses of antiepileptics–therapeutic drug monitoring as a marker of the quality of the treatment. Int J Clin Pharmacol Ther. 2006;44:438–42.

    Article  PubMed  CAS  Google Scholar 

  20. Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njolstad I, et al. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption-an individual-level prescription database study. BMC Clin Pharmacol. 2007;7:14.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Grimmsmann T, Himmel W. Relation between defined daily doses (DDD) and prescribed daily doses: a 3-month analysis of outpatient data from a statutory health insurance company. Gesundheitswesen. 2010;72:412–8.

    Article  PubMed  CAS  Google Scholar 

  22. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2012, Oslo, WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway, 2011.

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Agenzia Sanitaria e Sociale Regionale Emilia-Romagna, Viale Aldo Moro 21, 40127, Bologna, Italy

    C. Gagliotti, E. Ricchizzi, R. Buttazzi & M. L. Moro

  2. Azienda Ospedaliero Universitaria di Bologna, Via Massarenti, 11, 40138, Bologna, Italy

    F. Tumietto

  3. Azienda Unità Sanitaria Locale di Ravenna, Via Vittorio Veneto 8, 48012, Bagnacavallo, RA, Italy

    D. Resi

Authors
  1. C. Gagliotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Ricchizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Buttazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Tumietto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Resi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. L. Moro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Gagliotti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gagliotti, C., Ricchizzi, E., Buttazzi, R. et al. Hospital statistics for antibiotics: defined versus prescribed daily dose. Infection 42, 869–873 (2014). https://doi.org/10.1007/s15010-014-0649-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-014-0649-6

Keywords

Search

Navigation